Dr. Jaclyn Kovach, MD

Dr. Kovach practices at Bascom Palmer Eye Institute in Miami, Florida.

Dr. Kovach's NPI, 1174530323, was assigned on August 1, 2006. Dr. Kovach graduated from Vanderbilt University School Of Medicine in 2002. Dr. Kovach holds Florida license ME95906.

Dr. Kovach's primary practice is Bascom Palmer Eye Institute, at 900 NW 17th St, Miami, FL 33136 in Miami-Dade County. The practice phone is (239) 659-3937.

Dr. Kovach's primary practice is Bascom Palmer Eye Institute in Miami, Florida. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Kovach to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kovach practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Kovach's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Kovach is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Kovach is licensed in Florida.

Dmand AI lists age-related macular degeneration, cataract, conjunctivitis, dry eye, eyelid inflammation, glaucoma, glaucoma surgery and hereditary corneal conditions among the conditions Dr. Kovach treats.

CMS data shows 55,734 Medicare services from Dr. Kovach across 22 procedure codes in 2024, for 1,717 Medicare patients. Medicare paid $3,211,976 for them. Every service was in an office.

CMS counts 1,717 Medicare patients who saw Dr. Kovach in 2024. The largest group is 75 to 84, with 846 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 2% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kovach's median patient age at 78, with 57% women.

In 2024, Dr. Kovach wrote 805 Medicare Part D claims for 206 patients. 65% of them were for generic drugs. CMS names the drug for 689 of them, across 13 drugs with 11 or more claims each, at $66,546 in total drug cost. In 2023, CMS named 683 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Kovach for performance year 2024, reported as part of a group. Dr. Kovach accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 37 procedures of cataract surgery by Dr. Kovach, more than 57% of the clinicians it reports for that procedure.

Dmand AI links 46 papers to Dr. Kovach, published from 2009 to 2024. 2015 was the busiest year, with 5. The most frequent topics are Macular Degeneration, Tomography, Optical Coherence and Polymorphism, Single Nucleotide. Dr. Kovach has published most often in Invest Ophthalmol Vis Sci. Dr. Kovach's most frequent co-authors are Stephen G. Schwartz, MD, Anita Agarwal, MD and Milam A. Brantley, MD.

CMS Open Payments shows 273 general payments to Dr. Kovach from 20 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 51% of the total. Apellis Pharmaceuticals, Inc. paid the most, $117,471. It also lists 7 research payments totaling $929 in 2025, naming 1 clinical trial.

Dr. Kovach graduated from Vanderbilt University School Of Medicine in 2002.

Dr. Kovach is in network with 10 carriers, including Elevance, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.